This review discusses current thoughts on the pathogenesis of vasculitis. Secondary vasculitides, frequently associated with infections or systemic autoimmune diseases, are, in most cases, characterized by immune deposits in the vessel wall, which probably underlies the development of lesions. In the primary vasculitides, immune deposits are generally absent. A group of primary vasculitides is, however, strongly associated with anti-neutrophil cytoplasmic autoantibodies (ANCA). Various in vitro and in vivo experimental data suggest that those ANCA are involved in the pathogenesis of lesions in the associated disorders.
Somer T , Finegold SM . Vasculitides associated with infections, immunization and antimicrobial drugs . Clin Inf Dis1995; 20: 1010–1036 .
2.
Hunder GG et al. The American College of Rheumatology 1990 criteria for the classification of vasculitis . Arthritis Rheum1990; 33: 1065–1067 .
3.
Jennette JC et al. Nomenclature of systemic vasculitides: the proposal of an international consensus conference . Arthritis Rheum1994; 37: 187–192 .
4.
Lie JT . Nomenclature and classification of vasculitis: plus ça change, plus c'est la méme chose . Arthritis Rheum1994; 37: 181–186 .
5.
Theofilopoulos AN , Dixon FJ . Immune complexes in human diseases . Am J Pathol1980; 100: 530–594 .
6.
Bruggen MCJ van , Berden JHM . Central role for nucleosomes in lupus . Nephrol Dial Transplant1996; 11: 1219–1222 .
7.
Agnello V , Chung RT , Kaplan LM . Arolefor hepatitis C virusinfectionin type II cryoglobulinemia . N Engl J Med1992; 327: 1490–1495 .
8.
Guillevin L , Lhote F , Gherardi R . The spectrum and treatment of virus-associated vasculitides . Curr Op Rheumatol1997; 9: 31–36 .
9.
Yousif Y et al. Staphylococcal neutral phosphatase. A highly cationic molecule with binding properties for immunoglobulin . APMIS1991; 102: 897–900 .
10.
Kallenberg CGM . Laboratory findings in the vasculitides . Bailliere's Clin Rheumatol1997; 11: 395–421 .
11.
Kallenberg CGM , Brouwer E , Weening JJ , Cohen Tervaert JW . Anti neutrophil cytoplasmic antibodies: current diagnostic and pathophysiological potential . Kidney Int1994; 46: 1–15 .
12.
Cohen Tervaert JW , Stegeman CA , Kallenberg CGM . Serial ANCA testing is useful in monitoring disease activity of patients with ANCA-associated vasculitides . Sarcoidosis1996; 13: 241–245 .
13.
Falk RJ , Terrell RS , Charles LA , Jennette JC . Anti-neutrophilcytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro . Proc Natl Acad Sci1990; 87: 4115–4119 .
14.
Reumaux D , Vossebeld PJM , Roos D , Verhoeven AJ . Effects of tumor necrosis factor-induced integrin activation on Fcg receptor II-mediated signal transduction: relevance for activation of neutrophils by anti-proteinase 3 or anti-myeloperoxidase antibodies . Blood1995; 86: 3189–3195 .
15.
Csernok E et al. Activated neutrophils express proteinase 3 on their plasma membrane in vitro and in vivo . Clin Exp Immunol1994; 95: 244–250 .
16.
Gilligan HM et al. Antineutrophil cytoplasmic autoantibodies interact with primary granule constituents on the surface of apoptotic neutrophils in the absence of neutrophil priming . J Exp Med1996; 184: 2231–2241 .
17.
Mulder AHL et al. Activation of granulocytes by anti-neutrophil cytoplasmic antibodies (ANCA); a FcgRII-dependent process . Clin Exp Immunol1994; 78: 270–278 .
18.
Grimminger F et al. Neutrophil activation by anti-proteinase 3 antibodies in Wegener's Granulomatosis: Role of exogenous arachidonic acid and leukotriene B4 generation . J Exp Med1996; 184: 1567–1572 .
19.
Brooks CJ et al. IL-1b production by human polymorpho-nuclear leukocytes stimulated by anti-neutrophil cytoplasmic autoantibodies: relevance to systemic vasculitis . Clin Exp Immunol1996; 106: 273–279 .
20.
Ewert BH , Jennette JC , Falk RJ . The pathogenic role of anti-neutrophil cytoplasmic autoantibodies . Am J Kidney Dis1991; 18188–195 .
21.
Casselman BL , Kilgore KS , Miller BF , Warren JS . Antibodies to neutrophil cytoplasmic antigens induce monocyte chemoattractant protein-1 secretion from human monocytes . J Lab Clin Med1995; 126: 495–502 .
22.
Savage CO , Pottinger BE , Gaskin G , Pusey CD , Pearson JD . Autoantibodies developing to myeloperoxidase and proteinase 3 in systemic vasculitis stimulate neutrophil cytotoxicity towards cultured endothelial cells . Am J Path1992; 141: 335–342 .
Mayet WJ , Meyer zum Buschenfelde KH . Antibodies to proteinase 3 increase adhesion of neutrophils to human endothelial cells . Clin Exp Immunol1993; 94: 440–446 .
25.
Mayet WJ , Schwarting A , Meyer zum Buschenfelde KH . Cytotoxic effects of antibodies to proteinase 3 (C-ANCA) on human endothelial cells . Clin Exp Immunol1994; 97: 458–465 .
26.
Van der Wiel BA et al. Interference of Wegener's granulomatosis autoantibodies with neutrophil proteinase 3 activity . Clin Exp Immunol1992; 90: 409–414 .
27.
Mayet WJ et al. Human endothelial cells express proteinase 3, the target antigen of anticytoplasmic antibodies in Wegener's Granulomatosis . Blood1993; 82: 1221–1229 .
28.
King WJ et al. Endothelial cells and renal epithelial cells do not express the Wegener's autoantigen, proteinase 3 . Clin Exp Immunol1995; 102: 98–105 .
29.
Heeringa P et al. Animal models of anti-neutrophil cytoplasmic antibody associated vasculitis. Kidney Int (in press).
30.
Mathieson PW , Thiru S , Oliveira DBG . Mercuric chloride-treated Brown Norway rats develop widespread tissue injury including necrotizing vasculitis . Lab Invest1992; 67: 121–129 .
31.
Hewicker M , Trautwein G . Sequential study of vasculitis in MRL mice . Lab Anim1987; 21: 335–341 .
32.
Moyer CF , Strandberg DJ , Reinish CL . Systemic mononuclear cell vasculitis in MRL/Mp-lpr/lpr mice: a histological and immunocytochemical analysis . Am J Path1987; 127: 229–242 .
33.
Harper JM , Lockwood CM , Cooke A . Anti-neutrophil cytoplasm antibody in MRL-lpr/lpr mice . Clin Exp Immunol1993; 93(suppl 1): 22-22 .
34.
Kinjoh K , Kyogoku M , Good RA . Genetic selection for crescent formation yields mouse strain with rapidly progressive glomerulonephritis and small vessel vasculitis . Proc Natl Acad Sci1993; 90: 3413–3417 .
35.
Brouwer E et al. Anti-myeloperoxidase associated proliferative glomerulonephritis; an animal model . J Exp Med1993; 177: 905–914 .
36.
Yang JJ , Jennette JC , Falk RJ . Immune complex glomerulonephritis is induced in rats immunized with heterologous myeloperoxidase . Clin Exp Immunol1994; 97: 466–473 .
37.
Heeringa P et al. Systemic injection of products of activated neutrophils and H2O2 in myeloperoxidase-immunized rats leads to necrotizing vasculitis in the lungs and gut . Am J Path1997; 151: 131–139 .
38.
Blank M et al. Immunization with anti-neutrophil cytoplasmic antibody (ANCA) induces the production of mouse ANCA and perivascular lymphocyte infiltration . Clin Exp Immunol1995; 102: 120–130 .
39.
Stegeman CA et al. Association of chronic nasal carriage of Staphylococcus aureus and higher relapse rates in Wegener's granulomatosis . Ann Intern Med1994; 113: 12–17 .
40.
Stegeman CA , Cohen Tervaert JW , Jong de PE , Kallenberg CGM . Trimethoprim (Cotrimoxazole) for the prevention of relapses of Wegener's granulomatosis . N Engl J Med1996; 335: 16–20 .
41.
Brouwer E et al. T-cell reactivity to proteinase 3 and myeloperoxidase in patients with Wegener's granulomatosis . Clin Exp Immunol1994; 98: 448–453 .
42.
Leung DYM et al. Evidence for superantigen involvement in cardiovascular injury due to Kawasaki syndrome . J Immunol1995; 155: 5018–5021 .
43.
Simpson IJ et al. Peripheral blood T lymphocytes in systemic vasculitis: increased T cell receptor Vb2 gene usage in microscopic polyarteritis . Clin Exp Immunol1995; 101: 220–226 .
44.
Popa ER et al. Skewed TCR Vb usage in Wegener's Granulomatosis suggests stimulation by superantigens . J Am Soc Nephrol1997; 8: 543A–543A .
45.
Posnett DN , Sinha R , Kabak S , Russo C . Clonal populations of T cells in normal elderly humans: the T cell equivalents to ‘benign monoclonal gammopathy’ . J Exp Med1994; 179: 609–618 .
46.
Weyand CM , Goronzy JJ . Multisystem interactions in the pathogenesis of vasculitis . Curr Op Rheumatol1997; 9: 3–11 .
